Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
Completed · Phase 1
Conditions studied: Non-melanomatous Skin Cancer
In brief
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells and, when exposed to light, become active and kill the cancer cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have basal cell skin cancer.
Key facts
- Study ID
- NCT00017485
- Run by
- Roswell Park Cancer Institute
- People needed
- 6
- Starts
- 2000-01-01
- Expected to finish
- 2007-01-01
- Last updated by the study team
- 2011-03-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.